Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Pcn217 - Keeping Up With the Comparators: Trends in Targeted Cancer Therapies Becoming Right Comparators for Payers

Value in Health

English

Pcv54 - Estimated Economic Burden of Atrial Fibrillation in Germany, Italy, and the Uk

English

PRM38 Estimating SF-6D Health State Utility Values for Comorid Health Conditions

English

Prs9 - Switching From Subcutaneous Treprostinil to Inhaled Treprostinil in Pulmonary Arterial Hypertension Treatment and Economic Impact Evaluation

English

Pss31 - Cost Per Responder of Secukinumab Compared to Other Biologics in Moderate-To-Severe Plaque Psoriasis From the Private Payer Perspective in Brazil

English

Pcp65 - Key Considerations for the Collection of Patient Reported Outcome (Pro) Data in Real World (Rw) Studies

English

Pcv43 - Budget Impact Analysis of the Introduction of a Single-Pill Combination of Atorvastatin, Perindopril and Amlodipine in the Greek Setting

English

Pnd26 - Cost Implications of a Novel Weight Dosed Treatment for Highly Active Relapsing Multiple Sclerosis in Portugal

English

Pmh40 - Cost-Minimisation Analysis of Second Generation Long Acting Injectables (Risperidone , Paliperidone, and Aripiprazole) for Schizophrenia in Spanish Medium-Long Term Care Psychiatric Units

English

Pmd144 - Selective Health Benefit to Reduce Economic Burden of Patients: Case of Cancer Surgery

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Pcn217 - Keeping Up With the Comparators: Trends in Targeted Cancer Therapies Becoming Right Comparators for Payers

Pcv54 - Estimated Economic Burden of Atrial Fibrillation in Germany, Italy, and the Uk

PRM38 Estimating SF-6D Health State Utility Values for Comorid Health Conditions

Prs9 - Switching From Subcutaneous Treprostinil to Inhaled Treprostinil in Pulmonary Arterial Hypertension Treatment and Economic Impact Evaluation

Pss31 - Cost Per Responder of Secukinumab Compared to Other Biologics in Moderate-To-Severe Plaque Psoriasis From the Private Payer Perspective in Brazil

Pcp65 - Key Considerations for the Collection of Patient Reported Outcome (Pro) Data in Real World (Rw) Studies

Pcv43 - Budget Impact Analysis of the Introduction of a Single-Pill Combination of Atorvastatin, Perindopril and Amlodipine in the Greek Setting

Pnd26 - Cost Implications of a Novel Weight Dosed Treatment for Highly Active Relapsing Multiple Sclerosis in Portugal

Pmh40 - Cost-Minimisation Analysis of Second Generation Long Acting Injectables (Risperidone , Paliperidone, and Aripiprazole) for Schizophrenia in Spanish Medium-Long Term Care Psychiatric Units

Pmd144 - Selective Health Benefit to Reduce Economic Burden of Patients: Case of Cancer Surgery